Active, Not Recruiting
Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma
NCT04659811
- Conditions
- Central Nervous System Neoplasms, Grade I Meningioma, Adult, Grade II Meningioma, Adult, +11 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States